Guan et al. analyzed CGGA, TCGA and other databases and found that CMTM6 was highly expressed in glioblastoma multiforme and mesenchymal subtypes, and high expression of CMTM6 was related to poor prognosis [5]. Here, CMTM6 is linked to glioblastoma.